These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17148963)

  • 1. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.
    Bomsel M; Pastori C; Tudor D; Alberti C; Garcia S; Ferrari D; Lazzarin A; Lopalco L
    AIDS; 2007 Jan; 21(1):13-22. PubMed ID: 17148963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new prospective against HIV infection: induction of murin CCR5-downregulating antibodies.
    Barassi C; Marenzi C; Pastori C; Longhi R; Lazzarin A; Lopalco L
    New Microbiol; 2004 Apr; 27(2 Suppl 1):85-94. PubMed ID: 15646069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells.
    Chomont N; Hocini H; Gody JC; Bouhlal H; Becquart P; Krief-Bouillet C; Kazatchkine M; Bélec L
    Virology; 2008 Jan; 370(2):246-54. PubMed ID: 17920650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.
    Barassi C; Soprana E; Pastori C; Longhi R; Buratti E; Lillo F; Marenzi C; Lazzarin A; Siccardi AG; Lopalco L
    J Virol; 2005 Jun; 79(11):6848-58. PubMed ID: 15890924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells.
    Meng G; Wei X; Wu X; Sellers MT; Decker JM; Moldoveanu Z; Orenstein JM; Graham MF; Kappes JC; Mestecky J; Shaw GM; Smith PD
    Nat Med; 2002 Feb; 8(2):150-6. PubMed ID: 11821899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins.
    Hocini H; Bomsel M
    J Infect Dis; 1999 May; 179 Suppl 3():S448-53. PubMed ID: 10099117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
    Lopalco L; Barassi C; Pastori C; Longhi R; Burastero SE; Tambussi G; Mazzotta F; Lazzarin A; Clerici M; Siccardi AG
    J Immunol; 2000 Mar; 164(6):3426-33. PubMed ID: 10706739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells.
    Devito C; Broliden K; Kaul R; Svensson L; Johansen K; Kiama P; Kimani J; Lopalco L; Piconi S; Bwayo JJ; Plummer F; Clerici M; Hinkula J
    J Immunol; 2000 Nov; 165(9):5170-6. PubMed ID: 11046049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium.
    Shen R; Drelichman ER; Bimczok D; Ochsenbauer C; Kappes JC; Cannon JA; Tudor D; Bomsel M; Smythies LE; Smith PD
    J Immunol; 2010 Apr; 184(7):3648-55. PubMed ID: 20208001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women.
    Biasin M; Caputo SL; Speciale L; Colombo F; Racioppi L; Zagliani A; Blé C; Vichi F; Cianferoni L; Masci AM; Villa ML; Ferrante P; Mazzotta F; Clerici M
    J Infect Dis; 2000 Nov; 182(5):1365-74. PubMed ID: 11023460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
    Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
    AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission.
    Saïdi H; Magri G; Nasreddine N; Réquena M; Bélec L
    Virology; 2007 Feb; 358(1):55-68. PubMed ID: 16934308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1.
    Dezzutti CS; Guenthner PC; Cummins JE; Cabrera T; Marshall JH; Dillberger A; Lal RB
    J Infect Dis; 2001 Apr; 183(8):1204-13. PubMed ID: 11262202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection.
    Williams SB; Flanigan TP; Artenstein AW; VanCott TC; Smith D; Mayer K; Koup RA
    J Infect Dis; 1999 May; 179(5):1310-2. PubMed ID: 10191415
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucosal events in the pathogenesis of human immunodeficiency virus type 1 infection.
    Smith PD; Li L; Meng G
    J Infect Dis; 1999 May; 179 Suppl 3():S436-40. PubMed ID: 10099114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
    Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
    J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial inactivation of CCR5- and CXCR4- tropic HIV-1 by human urine.
    Auvert B; Jenabian MA; Saidi H; Lissouba P; Bélec L
    Arch Virol; 2011 Dec; 156(12):2181-6. PubMed ID: 21947506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.